Hormonal Health

Hello Inside Expands to the UK to Help Women Manage Their Hormones through Continuous Glucose Monitoring

It’s been a busy week at Hello Inside, a European digital health startup that uses continuous glucose monitoring (in short: CGM) to empower its users with data and insights about their bodies helping them make the best possible decisions when it comes to nutrition and health. The company’s mission is to make “scientific self care” a reality and it has now landed…

Forth Launches a New TV Campaign Focused on Perimenopause in the UK

Forth is the company behind MyFORM, an at-home hormone blood test, and on a mission to empower women to become experts of their own body through scientific knowledge and understanding. MyFORM tests the four key female hormones – FSH, Luteinising Hormone, Oestrogen and Progesterone, which allows Forth’s proprietary AI algorithm to predict how each hormone fluctuates across a woman’s individual cycle length.…

Hormone Health Startup Inne Adds $10M in Funding to Scale Production and Invest in R&D Ahead of Further Commercialization

Hormonal health focused hardware startup Inne has raised $8.8M in Series A+ funding led by DSM Ventures. Other investors in this recent round include Borski Fund, Calm Storm Ventures as well as a number of angels, including Wise’s Taavet Hinrikus, Crista Galli Ventures’ Dr. Fiona Pathiraja and Trivago’s Rolf Schromgens. The company closed an $8.8M Series A back in 2019. According to…

Hormonal Health Startup Hormona Raises £1.2M in Pre-Seed Funding to Prepare for Launch in Europe and the U.S.

London-based Hormona, a digital health startup focused on hormonal health, has raised £1.2M in pre-seed funding from Nascent Invest AB, Techstars and Blackheat Capital AB. The company plans to use the new funds for R&D and to grow the team ahead of its launch in Europe this fall, which will be followed by a U.S. launch in early 2023. Hormona was founded…

Women’s Health Biotech Company Oviva Raises $11.5M in Seed Funding to Address Ovarian Aging

Women’s health biotech company Oviva Therapeutics has announced an in-licensing agreement with Massachusetts General Hospital (MGH) of a family of patents, as well as $11.5M in seed funding, to develop first-in-class therapeutics to improve healthspan, the period of life spent in good health, in women. Oviva Therapeutics addresses the vast unmet need in women’s health by expanding funding, research, and clinical development of treatments…

Hertility Acquires Netherlands-based Hormone Testing Company Grip as It Gears Up for International Expansion

A couple of weeks ago Hertility took over London with its thought-provoking out-of-home campaign, but the company’s ambitions clearly aren’t limited to the UK. Today, as Hertility gears up for rapid international expansion, the company is announcing the acquisition of Netherlands-based competitor Grip. Until now, comprehensive data on women’s health hasn’t existed, but acquiring Grip will expand Hertility’s own dataset and help…

Serena Ventures-backed Hormonal Health Brand WILE Launches in Whole Foods Market with $3M in Pre-Seed Funding

WILE, a hormonal wellness brand focused on women going through perimenopause has raised $3M in pre-seed funding and will debut nine SKUs in all Whole Foods Market doors this month. The round was led by Serena Ventures with participation from Springdale Ventures, angel investor Sara Bright and Coyote Ventures. The company was co-founded by Gwen Floyd, Corey Scholibo, and Julie Kucinski alongside…

Elix’s New Herbal Supplement Uses Traditional Chinese Medicine (TCM) to Support Hormonal Health

Elix, a modern platform to deliver organic, personalized and clinically proven herbal healing formulas derived from Traditional Chinese Medicine (TCM), has seen quite some success since its launch in 2019 supporting women struggling with painful periods. Now the company, that has raised $2.7M to date, is adding a new product to its line-up: Daily Harmony, a clinical strength, natural hormone-balancing formula fortified…